Rogers (VTX:ROG) has been given a CHF 330 target price by Jefferies Financial Group in a report issued on Wednesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the healthcare company’s stock.
Several other equities research analysts have also recently weighed in on ROG. DZ Bank reaffirmed a “neutral” rating on shares of Rogers in a research report on Friday, April 23rd. Citigroup set a CHF 360 price objective on shares of Rogers and gave the stock a “buy” rating in a research report on Tuesday, March 9th. UBS Group set a CHF 330 price objective on shares of Rogers and gave the stock a “neutral” rating in a research report on Monday, March 22nd. Deutsche Bank Aktiengesellschaft set a CHF 325 price objective on shares of Rogers and gave the stock a “neutral” rating in a research report on Tuesday, March 23rd. Finally, Sanford C. Bernstein set a CHF 360 price objective on shares of Rogers and gave the stock a “buy” rating in a research report on Thursday, May 20th. One analyst has rated the stock with a sell rating, nine have given a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of CHF 342.38.
Rogers has a one year low of CHF 214.30 and a one year high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. It operates in Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), Power Electronics Solutions (PES), and Other segments. The ACS segment offers circuit materials and solutions for connectivity applications in wireless infrastructure, automotive, aerospace and defense, connected devices, and wired infrastructure under the RO4000, RO3000, RT/duroid, TMM, AD Series, CuClad, Kappa, DiClad, IsoClad, COOLSPAN, MAGTREX, TC Series, IM Series, 92ML, and CLTE Series names.
Receive News & Ratings for Rogers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rogers and related companies with MarketBeat.com's FREE daily email newsletter.